Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Angew Chem Int Ed Engl ; 59(38): 16631-16637, 2020 09 14.
Artigo em Inglês | MEDLINE | ID: mdl-32533618

RESUMO

Inducing necroptosis in cancer cells is an effective approach to circumvent drug-resistance. Metal-based triggers have, however, rarely been reported. Ruthenium(II) complexes containing 1,1-(pyrazin-2-yl)pyreno[4,5-e][1,2,4]triazine were developed with a series of different ancillary ligands (Ru1-7). The combination of the main ligand with bipyridyl and phenylpyridyl ligands endows Ru7 with superior nucleus-targeting properties. As a rare dual catalytic inhibitor, Ru7 effectively inhibits the endogenous activities of topoisomerase (topo) I and II and kills cancer cells by necroptosis. The cell signaling pathway from topo inhibition to necroptosis was elucidated. Furthermore, Ru7 displays significant antitumor activity against drug-resistant cancer cells in vivo. To the best of our knowledge, Ru7 is the first Ru-based necroptosis-inducing chemotherapeutic agent.


Assuntos
Complexos de Coordenação/farmacologia , DNA Topoisomerases Tipo I/metabolismo , Necroptose/efeitos dos fármacos , Proteínas de Ligação a Poli-ADP-Ribose/antagonistas & inibidores , Rutênio/farmacologia , Inibidores da Topoisomerase/farmacologia , Animais , Biocatálise/efeitos dos fármacos , Morte Celular/efeitos dos fármacos , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Complexos de Coordenação/síntese química , Complexos de Coordenação/química , DNA Topoisomerases Tipo II/metabolismo , Humanos , Camundongos , Estrutura Molecular , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/metabolismo , Neoplasias Experimentais/patologia , Proteínas de Ligação a Poli-ADP-Ribose/metabolismo , Rutênio/química , Inibidores da Topoisomerase/síntese química , Inibidores da Topoisomerase/química
2.
J Biol Inorg Chem ; 12(7): 1015-27, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17659367

RESUMO

Many antitumor drugs act as topoisomerase inhibitors, and the inhibitions are usually related to DNA binding. Here we designed and synthesized DNA-intercalating Ru(II) polypyridyl complexes Delta--[Ru(bpy)(2)(uip)](2+) and Lambda-[Ru(bpy)(2)(uip)](2+) (bpy is 2,2'-bipyridyl, uip is 2-(5-uracil)-1H-imidazo[4,5-f][1,10]phenanthroline). The DNA binding, photocleavage, topoisomerase inhibition, and cytotoxicity of the complexes were studied. As we expected, the synthesized Ru(II) complexes can intercalate into DNA base pairs and cleave the pBR322 DNA with high activity upon irradiation. The mechanism studies reveal that singlet oxygen ((1)O(2)) and superoxide anion radical (O (2) (*-) ) may play an important role in the photocleavage. The inhibition of topoisomerases I and II by the Ru(II) complexes has been studied. The results suggest that both complexes are efficient inhibitors towards topoisomerase II by interference with the DNA religation and direct topoisomerase II binding. Both complexes show antitumor activity towards HELA, hepG2, BEL-7402, and CNE-1 tumor cells.


Assuntos
DNA/química , Substâncias Intercalantes/química , Substâncias Intercalantes/síntese química , Piridinas/química , Rutênio/química , Inibidores da Topoisomerase II , Linhagem Celular Tumoral , Dicroísmo Circular , DNA/metabolismo , Humanos , Concentração Inibidora 50 , Substâncias Intercalantes/farmacologia , Estereoisomerismo , Termodinâmica
3.
J Inorg Biochem ; 100(9): 1487-94, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16766033

RESUMO

A novel polypyridyl ligand pteridino[7,6-f][1,10]phenanthroline-1,13(10H,12H)-dione (ppd) and its ruthenium(II) complex [Ru(bpy)2ppd]2+ have been synthesized and characterized by elemental analysis, electrospray mass spectra and 1H NMR. The interaction of the complex with calf thymus DNA was investigated by spectroscopic and viscosity measurements. The results suggest that the complex binds to DNA via an intercalative mode and serves as a molecular "light switch" for DNA. Moreover, the complex has been found to promote the photocleavage of plasmid DNA pBR322 under irradiation at 365 nm. The mechanism studies reveal that singlet oxygen (1O2) and superoxide anion radical (O2*(-))play a significant role in the photocleavage.


Assuntos
DNA/química , Substâncias Intercalantes/química , Compostos Organometálicos/química , Compostos de Rutênio/química , DNA/metabolismo , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Fotoquímica
4.
J Inorg Biochem ; 99(2): 530-7, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15621286

RESUMO

A novel asymmetric bidentate ruthenium (II) complex, [Ru(bpy)(2)(PYNI)](2+) (bpy=2,2'-bipyridine, PYNI=2-(2'-pyridyl)naphthoimidazole), has been synthesized and characterized by elemental analysis, ES-MS (electrospray mass spectra) and (1)H NMR. The electrochemical behaviors of this complex were studied by cyclic voltammetry. DNA interaction studies suggest that [Ru(bpy)(2)(PYNI)](2+) binds to calf thymus DNA (CT-DNA) in an intercalative mode. Interestingly, this new Ru(II) complex has also been found to promote cleavage of plasmid pBR 322 DNA from the supercoiled form I to the open circular form II upon irradiation.


Assuntos
DNA/efeitos dos fármacos , Compostos Organometálicos/química , Compostos Organometálicos/farmacologia , Animais , Bovinos , Técnicas In Vitro , Substâncias Intercalantes/síntese química , Substâncias Intercalantes/química , Substâncias Intercalantes/farmacologia , Ligantes , Luminescência , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Compostos Organometálicos/síntese química , Fotoquímica , Plasmídeos/efeitos dos fármacos , Rutênio , Espectrometria de Massas por Ionização por Electrospray , Espectrofotometria , Termodinâmica , Viscosidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...